These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 9013816)
1. Reduction in blood free carnitine levels in association with changes in sodium valproate (VPA) disposition in epileptic patients treated with VPA and other anti-epileptic drugs. Hiraoka A; Arato T; Tominaga I Biol Pharm Bull; 1997 Jan; 20(1):91-3. PubMed ID: 9013816 [TBL] [Abstract][Full Text] [Related]
2. Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients. Goto S; Seo T; Hagiwara T; Ueda K; Yamauchi T; Nagata S; Ando Y; Ishitsu T; Nakagawa K J Pharm Pharmacol; 2008 Feb; 60(2):267-72. PubMed ID: 18237476 [TBL] [Abstract][Full Text] [Related]
3. [The decreased level of plasma carnitine in patients with epilepsy]. Belousova ED Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):106-110. PubMed ID: 28745680 [TBL] [Abstract][Full Text] [Related]
4. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status. Hamed SA; Abdella MM Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440 [TBL] [Abstract][Full Text] [Related]
5. [Effects of antiepileptic drugs on delivery and early childhood--comparison among mono-therapies of valproic acid, phenytoin, carbamazepine and phenobarbital]. Tanaka H; Takeda A; Izumi M; Okada H; Ishikawa S Rinsho Shinkeigaku; 1991 Mar; 31(3):266-9. PubMed ID: 1893664 [TBL] [Abstract][Full Text] [Related]
6. Effects of discontinuation of phenytoin, carbamazepine, and valproate on concomitant antiepileptic medication. Duncan JS; Patsalos PN; Shorvon SD Epilepsia; 1991; 32(1):101-15. PubMed ID: 1985818 [TBL] [Abstract][Full Text] [Related]
7. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients. Zeng K; Wang X; Xi Z; Yan Y Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075 [TBL] [Abstract][Full Text] [Related]
8. Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS. Werner T; Treiss I; Kohlmueller D; Mehlem P; Teich M; Longin E; Gerstner T; Koenig SA; Schulze A Epilepsia; 2007 Jan; 48(1):72-6. PubMed ID: 17241210 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS. Nakajima Y; Ito T; Maeda Y; Ichiki S; Kobayashi S; Ando N; Hussein MH; Kurono Y; Sugiyama N; Togari H Brain Dev; 2011 Nov; 33(10):816-23. PubMed ID: 21196091 [TBL] [Abstract][Full Text] [Related]
10. Drug treatment of epilepsy in elderly people: focus on valproic Acid. Stephen LJ Drugs Aging; 2003; 20(2):141-52. PubMed ID: 12534314 [TBL] [Abstract][Full Text] [Related]
11. Alterations in the carnitine metabolism in epileptic children treated with valproic acid. Chung S; Choi J; Hyun T; Rha Y; Bae C J Korean Med Sci; 1997 Dec; 12(6):553-8. PubMed ID: 9443096 [TBL] [Abstract][Full Text] [Related]
12. Antiepileptic drugs alter reproductive endocrine hormones in men with epilepsy. Røste LS; Taubøll E; Mørkrid L; Bjørnenak T; Saetre ER; Mørland T; Gjerstad L Eur J Neurol; 2005 Feb; 12(2):118-24. PubMed ID: 15679699 [TBL] [Abstract][Full Text] [Related]
13. [Effect of carbamazepine and valproate on bone metabolism in children with epilepsy]. Song XQ; Wang ZP; Bao KR; Zhang JM; Wu J; Yan CH; Shen XM Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):728-32. PubMed ID: 16255847 [TBL] [Abstract][Full Text] [Related]
14. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Chuang YC; Chuang HY; Lin TK; Chang CC; Lu CH; Chang WN; Chen SD; Tan TY; Huang CR; Chan SH Epilepsia; 2012 Jan; 53(1):120-8. PubMed ID: 22085257 [TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. McKee PJ; Blacklaw J; Forrest G; Gillham RA; Walker SM; Connelly D; Brodie MJ Br J Clin Pharmacol; 1994 Jan; 37(1):27-32. PubMed ID: 8148215 [TBL] [Abstract][Full Text] [Related]
17. Factors associated with blood carnitine levels in adult epilepsy patients with chronic valproic acid therapy. Saito M; Takizawa T; Miyaoka H Epilepsy Res; 2021 Sep; 175():106697. PubMed ID: 34175794 [TBL] [Abstract][Full Text] [Related]
18. Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data. Blanco-Serrano B; Otero MJ; Santos-Buelga D; García-Sánchez MJ; Serrano J; Domínguez-Gil A Biopharm Drug Dispos; 1999 Jul; 20(5):233-40. PubMed ID: 10594867 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients]. Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630 [TBL] [Abstract][Full Text] [Related]
20. Drug interaction between valproic acid and carbapenems in patients with epileptic seizures. Huang CR; Lin CH; Hsiao SC; Chen NC; Tsai WC; Chen SD; Lu YT; Chuang YC Kaohsiung J Med Sci; 2017 Mar; 33(3):130-136. PubMed ID: 28254115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]